Kumar, N. B., Parker, N., Zhang, J., Pow-Sang, J., Park, J. Y., & Schell, M. J. (2026). Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention. Cancers, 18(8), 1276. https://doi.org/10.3390/cancers18081276
Chicago Style (17th ed.) CitationKumar, Nagi B., Nathan Parker, Jingsong Zhang, Julio Pow-Sang, Jong Y. Park, and Michael J. Schell. "Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention." Cancers 18, no. 8 (2026): 1276. https://doi.org/10.3390/cancers18081276.
MLA (9th ed.) CitationKumar, Nagi B., et al. "Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention." Cancers, vol. 18, no. 8, 2026, p. 1276, https://doi.org/10.3390/cancers18081276.